V028-0639 Screening compound: 1-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-1-(1-phenylethyl)-3-propylurea

V028-0639 Screening compound: 1-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-1-(1-phenylethyl)-3-propylurea
V028-0639 Screening compound: 1-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-1-(1-phenylethyl)-3-propylurea alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-0639
1-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-1-(1-phenylethyl)-3-propylurea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-0639

Molecular Formula

C29H36N6O2 (C29 H36 N6 O2)

Compound Name

1-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-1-(1-phenylethyl)-3-propylurea

IUPAC name

1-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-1-(1-phenylethyl)-3-propylurea

SMILES

CCCNC(N(CC(N(CC1)CCN1c(cc1)nnc1-c1ccc(C)cc1)=O)C(C)c1ccccc1)=O

InChI

InChI=1S/C29H36N6O2/c1-4-16-30-29(37)35(23(3)24-8-6-5-7-9-24)21-28(36)34-19-17-33(18-20-34)27-15-14-26(31-32-27)25-12-10-22(2)11-13-25/h5-15,23H,4,16-21H2,1-3H3,(H,30,37)/t23-/m0/s1

InChI Key

VYEFYTPZCOMSDF-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD19840400

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

500.64

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.956

Distribution Coefficient, logD

4.936

Water Solubility, LogSw

-4.47

Polar Surface Area

66.386

Acid Dissociation Constant (pKa)

17.72

Base Dissociation Constant (pKb)

6.09

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

37.90

V028-0639 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with V028-0639 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-0639?
Check Price and Availability of V028-0639, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-0639 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-0639
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-0639
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-0639 available by request